Organization

Cima Universidad de Navarra


FIMA Board of Trustees

The Fundación para la Investigación Médica Aplicada (FIMA) is the titular entity of the Cima Universidad de Navarra. It was established in 1998 and, after five decades of experience in biomedical research, FIMA created the Cima in 2004. The foundation consists of a president and five trustees:

President: Mr. Enrique de Sendagorta.

Honorary members:

  • Mr. Antonio Catalán
  • Mr. Antonio Trueba
  • Mr. Javier Olave

Members of the Board of Trustees:

  • Mr. Jorge Lucaya (vice-chairman)
  • Mr. Igor Errasti (secretary)
  • Ms. Paloma Grau (member)
  • Mr. Miguel Sanz (member)
  • Ms. Isabel Estapé (member)

The Board of Trustees is responsible for appointing the Cima Steering Committee, proposed by the Universidad de Navarra.

Governing Bodies

The Cima of the Universidad de Navarra is a University Research Institute that depends organically on the Rectorate of the Universidad de Navarra.

Management Committee

The Cima Steering Committee is proposed by the Universidad de Navarra and its appointment corresponds to FIMA. Together with the Rectorate, it is responsible for balancing the budget.


José Andrés
Gómez Cantero

General director
Icono correo electrónico
jgcantero@unav.es


Antonio Pineda Lucena
Scientific Director
Icono correo electrónico

apinedal@unav.es 


Rubén Pío Osés
Deputy Scientific Director
Icono correo electrónico

rpio@unav.es

Lucía Vanrell Majo
Transfer and Innovation Director

Icono correo electrónico
lvanrell@unav.es


María Mora Catalá
Manager
Icono correo electrónico
mmora@unav.es

The Scientific Advisory Board is made up of researchers who are program directors in different scientific areas of the Cima and other prestigious researchers.

  • Dr. Matías Ávila, codirector of the Solid Tumors Program.
  • Dr. Rubén Pío, deputy scientific director  and director of the Cancer Division.
  • Dr. Felipe Prósper, director of the Regenerative Medicine program and co-director of the Hemato-Oncology Program.
  • Dr. Arantxa González Miqueo, director of the Cardiovascular Diseases Program.
  • Dr. Cristian Smerdou, director of the Gene Therapy and Regulation of Gene Expression Program.
  • Dr. Juan José Lasarte, director of the Immunology and Immunotherapy Program.
  • Dr. Antonio Pineda-Lucena, director of the Molecular Therapies Program.
  • Dr. Mikel Hernáez, Director of the Computational Biology Program.
  • Dr. Carlos Ortiz de Solórzano, Director of the Imaging Platform.
  • Dr. Bruno Paiva, Director of the Cytometry Technology Platform.
  • Dr. Fernando Lecanda, director of the Adhesion and Metastasis group within the Solid Tumors Program.
  • Dr. Ignacio Melero, senior researcher in the Immunology and Immunotherapy Program.

The External Scientific Council is made up of prestigious national and international researchers:

  • Margarita Del Val, PhD, Director of the Viral Immunology Unit of CSIC.
  • Jean Charles Soria, MD, PhD, Senior Vice Presiden and Head of the Oncology Therapeutic Area of AMGEN.
  • Francisco Sánchez Madrid, PhD, Scientific Director of the Instituto de Investigación Sanitaria del Hospital de La Princesa.
  • Juan Bueren, PhD, Head of the Division of Innovative Therapies in the Hematopoietic System at CIEMAT.
  • Ángel Carracedo, MD, PhD, Professor of Genomic Medicine at the University of Santiago de Compostela.
  • Miao Chich Tsai, PhD, Scientific Director of the RNA Medicine Program at Stanford University.
  • Marcela Maus, MD, PhD, Director of Cellular Immunotherapy at the Massachusetts General Hospital Cancer Center.
  • Jude Samulski, PhD, Director of the Center for Gene Therapy at the University of North Caroline. Founder of Askbio.

Central Services


General Manager


Financial Management and Administration


Personnel Services


Research Management


Institutional Development


Translation and Innovation Unit


General Services


Communication